Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Despite Few Actions On Rx Drug Promos, US FDA Increased Engagement With Stakeholders Last Year

Feb 08 2022

• By Brenda Sandburg

pharma advertising — US FDA objected to five prescription drug promotions in 2021 • Source: Alamy

Related Content

Dsuvia Gets Warning Letter As US FDA’s Opioid Decisions Complicate Commissioner Race

Feb 17 2021

US FDA’s ‘Bad Ad’ Program Snares Paragard Contraceptive TV Video Promo

Feb 25 2021

Tom Abrams’ Steady Leadership Guided US FDA Through Dramatic Changes In Rx Promotion

Oct 28 2020

Amgen’s Neulasta Ad Indirectly Targeting Biosimilars Draws US FDA Rebuke

Jul 15 2021

DTC For Accelerated Approval Drugs: US FDA Is Taking Another Look At Disclosure On Websites

Jun 11 2021

Evolution of Rx Drug Promotion: Researchers Eye Data Brokers, Digital Tools, Global Influencers

Dec 03 2021

Pharma Companies Must Assure Their ‘House Is In Order’ As FTC Takes Aim At Deceptive Endorsements

Oct 20 2021

US FDA Actions On Rx Drug Promos Covered New Territory Last Year

Jan 12 2021

PhRMA Criticizes 'Exponential Pace' Of FDA Rx Drug Advertising Studies

Aug 14 2018

New Social Media Guidance From US FDA May Be On The Horizon

Nov 04 2020

US FDA To Screen Rx Drug Launch Promos Prior To Initiating Review

Dec 17 2020

US FDA Once Again Dings Rx Drug Sponsored Link For Excluding Risk Information

Aug 25 2021

Do Ads Noting A Drug’s ‘Targeted’ Mechanism Of Action Impact Perceptions Of the Product?

Nov 02 2021

Lilly Resolves US FDA Concerns About Emgality TV Ads That Were Not Meant To Run Solo

Jan 17 2022

FDA Creates Division To Support First Amendment Policy Development, Oversee Advertising Research

Jan 07 2022

Lilly Gets First Of Its Kind FDA Citation For Trulicity Instagram Post

Jan 26 2022

Keeping Up With the Kardashians: US FDA Objects To Khloé’s Migraine Drug Promo

Mar 10 2021

Related Companies

CooperSurgical Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Eton Pharmaceuticals, Inc.

Amgen, Inc.

Talphera, Inc.

Eli Lilly and Company

Biogen, Inc.

Eisai Co., Ltd.

Additional Topics

United States Advertising, Marketing & Sales Leadership Warning Letters Enforcement Regulation Pink Sheet Perspectives BioPharmaceutical

More from Pink Sheet Perspectives

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window